Plasmid-based controls to detect rpoB mutations in Mycobacterium tuberculosis by quantitative polymerase chain reaction-high-resolution melting

• Autor(a) principal: Silva, Joas Lucas da
• Data de Publicação: 2013
• Outros Autores: Leite, Gabriela Guimaraes Sousa, Bastos, Gisele Medeiros, Lucas, Beatriz Cacciacarro, Shinohara, Daniel Keniti, Takinami, Joice Sayuri, Miyata, Marcelo, Fajardo, Cristina Moreno, Luchessi, André Ducati, Leite, Clarice Queico Fujimura [UNESP], Cardoso, Rosilene Fressatti, Hirata, Rosario Dominguez Crespo, Hirata, Mario Hiroyuki
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UNESP
• Texto Completo: http://dx.doi.org/10.1590/S0074-02762013000100017; http://hdl.handle.net/11449/7948
• topic: drug resistance; rifampicin; Mycobacterium tuberculosis

Quantitative polymerase chain reaction-high-resolution melting (qPCR-HRM) analysis was used to screen for mutations related to drug resistance in Mycobacterium tuberculosis. We detected the C526T and C531T mutations in the rifampicin resistance-determining region (RRDR) of the rpoB gene with qPCR-HRM using plasmid-based controls. A segment of the RRDR region from M. tuberculosis H37Rv and from strains carrying C531T or C526T mutations in the rpoB were cloned into pGEM-T vector and these vectors were used as controls in the qPCR-HRM analysis of 54 M. tuberculosis strains. The results were confirmed by DNA sequencing and showed that recombinant plasmids can replace genomic DNA as controls in the qPCR-HRM assay. Plasmids can be handled outside of biosafety level 3 facilities, reducing the risk of contamination and the cost of the assay. Plasmids have a high stability, are normally maintained in Escherichia coli and can be extracted in large amounts.